This study is conducted in Asia. This study is a prospective, open, uncontrolled, observational surveillance study with Levemir® FlexPen® conducted in Korea. The aim of this observational study is to evaluate the short term and the long term safety and efficacy of Levemir® FlexPen®. The study is planned and conducted as per requirement from Korea Food and Drug Administration (KFDA).
Study Type
OBSERVATIONAL
Enrollment
797
Start dose and frequency to be prescribed by the physician as a result of the normal clinical evaluation
Unnamed facility
Pusan, South Korea
Incidence of adverse events
Time frame: for the duration of the trial
Weight
Time frame: for the duration of the trial
FBG (Fasting Blood Glucose)
Time frame: for the duration of the trial
2hr-PPBG (2hr-Post Prandial Blood Glucose)
Time frame: for the duration of the trial
HbA1c
Time frame: for the duration of the trial
Adverse events
Time frame: for the duration of the trial
Clinical laboratory abnormality
Time frame: for the duration of the trial
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.